Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 8873738)

Published in J Thorac Cardiovasc Surg on October 01, 1996

Authors

T J Vander Salm1, S Kaur, R A Lancey, O N Okike, A T Pezzella, R F Stahl, L Leone, J M Li, C R Valeri, A D Michelson

Author Affiliations

1: Division of Cardiothoracic Surgery, University of Massachusetts Medical Center, Worcester 01655-0333, USA.

Articles by these authors

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72

Direct interaction of Arabidopsis cryptochromes with COP1 in light control development. Science (2001) 3.19

Primary cardiac valve tumors. Ann Thorac Surg (1991) 2.85

The platelet function defect of cardiopulmonary bypass. Blood (1993) 2.63

Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation (2001) 2.54

Country profile: India. Lancet (1998) 2.40

Electrical wiring configurations and childhood leukemia in Rhode Island. Am J Epidemiol (1980) 2.40

An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes. N Engl J Med (2000) 2.21

Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol (1992) 2.19

Involvement of the family members in caring of patients an acute care setting. J Postgrad Med (2014) 2.18

A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science (1990) 2.16

Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia. J Thromb Haemost (2011) 2.11

Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene (2010) 2.10

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood (1999) 2.08

Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol (1999) 2.08

Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol (1982) 1.96

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol (1998) 1.95

Does erythrocyte infusion improve 3.2-km run performance at high altitude? Eur J Appl Physiol Occup Physiol (1998) 1.94

In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 1.90

Electrical alternans and cardiac electrical instability. Circulation (1988) 1.86

Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci U S A (1972) 1.84

Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79

Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol (1989) 1.77

Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage. Eur J Clin Microbiol (1983) 1.76

Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia. Clin Exp Allergy (2007) 1.74

Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol (2001) 1.74

Isolation and characterization of the TRM1 locus, a gene essential for the N2,N2-dimethylguanosine modification of both mitochondrial and cytoplasmic tRNA in Saccharomyces cerevisiae. J Biol Chem (1986) 1.71

Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol (1999) 1.70

A signal-anchor sequence selective for the mitochondrial outer membrane. J Cell Biol (1992) 1.68

Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost (1994) 1.66

Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol (1999) 1.64

Lichen planus pigmentosus. J Am Acad Dermatol (1989) 1.64

Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol (1999) 1.61

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol (1993) 1.58

Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg (1991) 1.57

Characterization of glucokinase regulatory protein-deficient mice. J Biol Chem (2000) 1.56

Ophiasis inversus: a rare pattern of alopecia areata. Pediatr Dermatol (1998) 1.54

Clinical features of convulsive status epilepticus: a study of 220 cases in western China. Eur J Neurol (2009) 1.53

Superficial granulomatous pyoderma: an idiopathic granulomatous cutaneous ulceration. J Eur Acad Dermatol Venereol (2002) 1.53

Internal mammary artery grafts: the shortest route to the coronary arteries. Ann Thorac Surg (1989) 1.53

Images in clinical medicine. A grade 6 systolic murmur. N Engl J Med (1999) 1.52

Hypothermia-induced reversible platelet dysfunction. Ann Surg (1987) 1.51

Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg (1995) 1.51

Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation. Circulation (2001) 1.46

Ectopic ossification after median sternotomy. Ann Thorac Surg (1989) 1.46

GEISHA: an in situ hybridization gene expression resource for the chicken embryo. Cytogenet Genome Res (2007) 1.46

Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg (1999) 1.45

Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. Ann Thorac Surg (1994) 1.45

Keratitis, ichthyosis, deafness (KID) syndrome--the first report from India. Clin Exp Dermatol (1993) 1.43

Antithrombotic therapy in children. Chest (2001) 1.42

Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myeloma. Int J Radiat Oncol Biol Phys (1988) 1.41

Oral lesions of lichen planus. Int J Dermatol (1993) 1.41

Reliability and validity of a brief physical activity assessment for use by family doctors. Br J Sports Med (2005) 1.41

Odor in pemphigus. Dermatology (1992) 1.40

Separation of an overtube from the bite block during band ligation of esophageal varices. Gastrointest Endosc (1997) 1.39

Pemphigus in pregnancy. Am J Obstet Gynecol (1989) 1.39

Gsh-1: a novel murine homeobox gene expressed in the central nervous system. Dev Dyn (1995) 1.37

European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost (1998) 1.37

Platelet size as a determinant of platelet function. J Lab Clin Med (1983) 1.37

Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg (1993) 1.34

Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycerate, potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells. J Lab Clin Med (1969) 1.34

Aminolevulinic acid dehydratase in pea (Pisum sativum L.). Identification of an unusual metal-binding domain in the plant enzyme. J Biol Chem (1991) 1.31

Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum (1998) 1.30

Arachidonic acid metabolism by platelets of differing size. Br J Haematol (1983) 1.29

Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest (1996) 1.29

Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest (1997) 1.28

Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost (2013) 1.25

Gsh-4 encodes a LIM-type homeodomain, is expressed in the developing central nervous system and is required for early postnatal survival. EMBO J (1994) 1.25

Infrared fibers for radiometer thermometry in hypothermia and hyperthermia treatment. IEEE Trans Biomed Eng (1989) 1.22

Platelet size and age determine platelet function independently. Blood (1984) 1.22

The relation between response to hypotonic stress and the 51Cr recovery in vivo of preserved platelets. Transfusion (1974) 1.21

Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol (1996) 1.21

QTL detection for eating quality of cooked rice in a population of chromosome segment substitution lines. Theor Appl Genet (2004) 1.21

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol (1998) 1.21

Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ Res (1999) 1.20

Platelet size does not correlate with platelet age. Blood (1983) 1.19

Pulmonary edema after aneurysm surgery is modified by mannitol. Ann Surg (1989) 1.19

Concomitant occurrence of leprosy and tuberculosis--a clinical, bacteriological and radiological evaluation. Lepr India (1982) 1.19

Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion (1999) 1.18

Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost (2009) 1.18

Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. Br J Cancer (2009) 1.17

An ultrastructural and immunohistochemical study on the delta antigen associated with the hepatitis B virus. J Pathol (1979) 1.16

Anti-inflammatory activity of Euphorbia acaulis Roxb. J Ethnopharmacol (1984) 1.16

Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells. J Bone Joint Surg Am (1991) 1.16

Elevated hydroperoxide levels and antioxidant patterns in Papillon-Lefèvre syndrome. J Periodontol (2001) 1.15

Membranous obstruction of hepatic venous flow. Tex Heart Inst J (1995) 1.15

Effect of strenuous exercise on platelet activation state and reactivity. Circulation (1993) 1.15

The role of anticoagulation in the measurement of platelet volumes. Am J Clin Pathol (1983) 1.15

The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem (1998) 1.15

Myocardial depression during sepsis. Am J Surg (1977) 1.13

Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop Relat Res (1994) 1.13

Red-cell 2,3-diphosphoglycerate and creatine levels in patients with red-cell mass deficits or with cardiopulmonary insufficiency. N Engl J Med (1969) 1.13

Aneurysm following ligation of patent ductus arteriosus. Tex Heart Inst J (1995) 1.13

Parameter estimation in a Gompertzian stochastic model for tumor growth. Biometrics (2000) 1.13

Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Ann Surg (1992) 1.13

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B. J Clin Oncol (1993) 1.12